SCHEMBL3975619

SCHEMBL3975619

COC(=O)c1occ(-c2ccccc2)c1CO[Si](C)(C)C(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.37
POLB P06746 1/20 0.37
ALDH1A1 P00352 2/20 0.36
MAPT P10636 1/20 0.36
BACE1 P56817 1/20 0.36
GABRA1 P14867 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA5 P31644 1/20 0.36
GABRA3 P34903 1/20 0.36
TACR1 P25103 1/20 0.36
HTT P42858 1/20 0.35
PIN1 Q13526 1/20 0.35
GSK3B P49841 1/20 0.35
PTGS1 P23219 2/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
KMT2A Q03164 1/20 0.34
PRKCZ Q05513 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3977607 0.87 TACR1 (0.37) NPC1POLBALDH1A1MAPTBACE1
SCHEMBL3977656 0.81 TACR1 (0.41) POLBALDH1A1MAPTBACE1TACR1
SCHEMBL3974640 0.81 HTT (0.42) NPC1POLBALDH1A1MAPTGABRA1
SCHEMBL3979178 0.79 L3MBTL1 (0.44) NPC1POLBALDH1A1MAPTGABRA1
SCHEMBL974896 0.74 ALDH1A1 (0.42) ALDH1A1MAPTGABRA1GABRG2GABRB3
SCHEMBL3977063 0.72 LMNA (0.45) ALDH1A1MAPTGABRA1GABRG2GABRB3
SCHEMBL4279549 0.72 TACR1 (0.41) NPC1POLBALDH1A1MAPTBACE1
SCHEMBL28962190 0.71 SLC6A4 (0.45) NPC1POLBALDH1A1MAPTGABRA1
SCHEMBL3977272 0.71 TACR1 (0.43) POLBALDH1A1MAPTBACE1TACR1
SCHEMBL25591913 0.69 ALDH1A1 (0.50) NPC1POLBALDH1A1BACE1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 NPC1 1584/4885POLB 4676/4885ALDH1A1 1389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.